Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3

被引：77

作者：

Liakina, V. ^{[1
,2
]}

Hamid, S. ^{[3
]}

Tanaka, J. ^{[4
]}

Olafsson, S. ^{[5
]}

Sharara, A. I. ^{[6
]}

Alavian, S. M. ^{[7
,8
]}

Gheorghe, L. ^{[9
]}

El Hassan, E. S. ^{[10
]}

Abaalkhail, F. ^{[11
]}

Abbas, Z. ^{[12
]}

Abdou, A. ^{[10
]}

Abourached, A. ^{[13
]}

Al Braiki, F. ^{[14
]}

Al Hosani, F. ^{[15
]}

Al Jaberi, K. ^{[16
]}

Al Khatry, M. ^{[17
]}

Al Mulla, M. A. ^{[15
]}

Al Quraishi, H. ^{[18
]}

Al Rifai, A. ^{[19
]}

Al Serkal, Y. ^{[20
]}

Alam, A. ^{[21
]}

Alashgar, H. I. ^{[22
]}

Alawadhi, S. ^{[10
]}

Al-Dabal, L. ^{[23
]}

Aldins, P. ^{[24
]}

Alfaleh, F. Z. ^{[25
]}

Alghamdi, A. S. ^{[26
]}

Al-Hakeem, R. ^{[27
]}

Aljumah, A. A. ^{[28
,29
]}

Almessabi, A. ^{[14
]}

Alqutub, A. N. ^{[26
]}

Alswat, K. A. ^{[30
]}

Altraif, I. ^{[28
,29
]}

Alzaabi, M. ^{[31
]}

Andrea, N. ^{[32
]}

Assiri, A. M. ^{[27
]}

Babatin, M. A. ^{[26
]}

Baqir, A. ^{[33
]}

Barakat, M. T. ^{[34
]}

Bergmann, O. M. ^{[5
]}

Bizri, A. R. ^{[35
]}

Blach, S. ^{[36
]}

Chaudhry, A. ^{[37
]}

Choi, M. S. ^{[38
]}

Diab, T. ^{[39
]}

Djauzi, S. ^{[40
]}

El Khoury, S. ^{[41
]}

Estes, C. ^{[36
]}

Fakhry, S. ^{[42
]}

Farooqi, J. I. ^{[43
,44
]}

机构：

[1] Vilnius State Univ, Fac Med, Ctr Hepatol Gastroenterol & Dietet, Vilnius, Lithuania

[2] Vilnius Gediminas Tech Univ, Dept Biomech, Vilnius, Lithuania

[3] Aga Khan Univ, Karachi, Pakistan

[4] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan

[5] Landspitali, Div Gastroenterol & Hepatol, Reykjavik, Iceland

[6] Amer Univ Beirut, Med Ctr, Div Gastroenterol, Beirut, Lebanon

[7] Baqiatallah Univ Med Sci, Baqiatallah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran

[8] Middle East Liver Dis Ctr, Tehran, Iran

[9] Fundeni Clin Inst, Ctr Gastroenterol & Hepatol, Bucharest, Romania

[10] Rashid Hosp, Dubai Hlth Author, Dubai, U Arab Emirates

[11] Alfaisal Univ, King Faisal Specialist Hosp & Res Ctr, Dept Liver & Small Bowel Transplantat, Riyadh, Saudi Arabia

[12] Ziauddin Univ, Karachi, Pakistan

[13] Minist Publ Hlth, Natl Hepatitis Program, Beirut, Lebanon

[14] Abu Dhabi Hlth Serv Co, Abu Dhabi, U Arab Emirates

[15] Hlth Author Abu Dhabi, Communicable Dis Dept, Abu Dhabi, U Arab Emirates

[16] Hlth Author Abu Dhabi, Hlth Regulat Div, Abu Dhabi, U Arab Emirates

[17] Ras Al Khaimah Hosp, Ras Al Khaymah, U Arab Emirates

[18] Dubai Hlth Author, Dubai, U Arab Emirates

[19] Mafraq Hosp, Abu Dhabi, U Arab Emirates

[20] Minist Hlth, Hosp Sect, Al Ain, U Arab Emirates

[21] Shaikh Zayed Hosp, Lahore, Pakistan

[22] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia

[23] Rashid Hosp, Dubai Hlth Author, Dept Pulm Med, Dubai, U Arab Emirates

[24] Pauls Stradins Clin Univ Hosp, Infect Control Dept, Riga, Latvia

[25] King Saud Univ, Liver Dis Res Ctr, Riyadh, Saudi Arabia

[26] King Fahad Hosp, Dept Med Specialties, Gastroenterol & Hepatol Unit, Riyadh, Saudi Arabia

[27] Minist Hlth, Dept Prevent Med, Riyadh, Saudi Arabia

[28] King Abdul Aziz Med City, Riyadh, Saudi Arabia

[29] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia

[30] King Saud Univ, Coll Med, Liver Dis Res Ctr, Dept Med, Riyadh 11461, Saudi Arabia

[31] Zayed Mil Hosp, Abu Dhabi, U Arab Emirates

[32] Daman Natl Hlth Insurance Co, Abu Dhabi, U Arab Emirates

[33] Seyal Med Ctr, Multan, Pakistan

[34] Hlth Author Abu Dhabi, Abu Dhabi, U Arab Emirates

[35] Amer Univ Beirut, Med Ctr, Fac Med, Div Infect Dis, Beirut, Lebanon

[36] Ctr Dis Anal, Louisville, CO 80026 USA

[37] Siddiq Sadiq Hosp, Gujranwala Liver Fdn, Gujranwala, Pakistan

[38] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea

[39] Al Ain Hosp, Al Ain, U Arab Emirates

[40] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Fac Med, Div Hepatobiliary,Dept Internal Med, Jakarta, Indonesia

[41] Univ Balamand, St George Hosp, Dept Gastroenterol, Balamand, Lebanon

[42] Abu Dhabi Police, Abu Dhabi, U Arab Emirates

[43] Khyber Med Univ, Postgrad Med Inst, Peshawar, Pakistan

[44] Govt Lady Reading Hosp, Peshawar, Pakistan

[45] Landspitali, Reykjavik, Iceland

[46] Lady Reading Hosp, Dept Gastroenterol & Hepatol, Peshawar, Pakistan

[47] Univ Med Victor Babes, Gastroenterol Clin, Timisoara, Romania

[48] Landspitali, Sch Hlth Sci, Fac Med, Reykjavik, Iceland

[49] Univ Med Ctr, Clin Infect Dis & Febrile Illnesses, Ljubljana, Slovenia

[50] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia

来源：

JOURNAL OF VIRAL HEPATITIS | 2015年 / 22卷

关键词：

diagnosis; disease burden; epidemiology; hepatitis C; hepatitis C virus; historical; incidence; mortality; prevalence; treatment; FUTURE DISEASE BURDEN; TODAYS TREATMENT PARADIGM; BLOOD-DONORS; SAUDI-ARABIA; INFECTION; PREVALENCE; GENOTYPES; PAKISTAN; POPULATION; STRATEGIES;

D O I：

10.1111/jvh.12475

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7001000 cases) and Indonesia (3187000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

引用

页码：4 / 20

页数：17

共 70 条

[1]

Abdullah SM, 2013, MALAYS J MED SCI, V20, P41

[2]

Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence [J].

Abozaid, Suhair M. ;

Shoukri, Mohamed ;

Al-Qahtani, Ahmad ;

Al-Ahdal, Mohammed N. .

ANNALS OF SAUDI MEDICINE, 2013, 33 (01) :1-5

[3]

Abro AH, 2010, J PAK MED ASSOC, V60, P987

[4]

Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009 [J].

Al Shaer, Laila ;

AbdulRahman, Mahera ;

John, Thomas J. ;

AlHashimi, Ali .

TRANSFUSION, 2012, 52 (11) :2300-2309

[5]

PROFILE OF HEPATITIS-C VIRUS AND THE POSSIBLE MODES OF TRANSMISSION OF THE VIRUS IN THE GIZAN AREA OF SAUDI-ARABIA - A COMMUNITY-BASED STUDY [J].

ALFALEH, FZ ;

RAMIA, S ;

ARIF, M ;

AYOOLA, EA ;

ALRASHED, RS ;

ALJEFFRY, M ;

HOSSAIN, A ;

ELHAZMI, M .

ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1995, 89 (04) :431-437

[6]

[Anonymous], 2009, GROW THREATS HEP B C

[7]

[Anonymous], INF DIS STAT 2002 20

[8]

[Anonymous], AFH

[9]

[Anonymous], DETERMINATION HEPATI

[10]

[Anonymous], 2012 ANN REP

← 1 2 3 4 5 6 7 →